2002

“EVENTS” 3D text surrounded by calendar dates. Part of a series.

  • December 2002 – Antibody Engineering, IBC Lifesciences, December 1-4, 2002, San Diego, CA, “Antibiomix™ for Disease Phenotype” Invited Speaker, Dr. Moncef Jendoubi
  • October 2002 – Chips to Hits 2002, IBC Lifesciences, October 27-31, 2002, Philadelphia, PA, “Antibody-Based Target Discovery Via Matrix Protein Arrays” Invited Speaker, Dr. Moncef Jendoubi
  • October 2002 – SELDI-Prostate Cancer – PCPT Meeting, Early Detection Research Network, The University of Texas Health Science Center at San Antonio, TX, Invited Guest, Dr. Moncef Jendoubi
  • September 30, 2002 – National Institutes of Health, Bethesda, MD, “From Gene Products to Disease Phenotype: Antibody Chips for Predictive Medicine in Cancer” Invited Speaker, Dr. Moncef Jendoubi. Seminar to be webcasted between 2:00-4:00 p.m. ET linkwebcast
  • September 2002 – EDRN Steering Committee Meeting, Public Private Partnership Workshop, Early Detection Research Network, September 3-6, 2002, University of Michigan, Ann Arbor, MI, Invited Guest, Dr. Moncef Jendoubi
  • August 26, 2002 – “Aspiring to pharmaceuticals, Milagen hopes to sell antibodies arrays in the short run” John S. McNeil, ProteoMonitor, Vol. 2, No. 33, pp 3, a view at Milagen from the global newsweekly of proteomic technology
  • August 2002 – Cancer Genetics & Tumor Suppressor Genes, Cold Spring Harbor Laboratory, August 14-18, 2002, New York, NY, “Breaking the Bottleneck of Genomics and Proteomics” Invited Speaker, Dr. Moncef Jendoubi
  • August 2002 – Drug Discovery Technology 2002, IBC LifeSciences, August 5-9, 2002, Boston, MA, C. Chavany, J-F. Martini, R.P.C. Valle, M. Jendoubi, “Antibiomix(TM): Antibody-based Target Discovery and Validation for Diagnostics and Therapeutics” Poster Presentation, Dr. Rosaura Valle
  • July/August 2002 (PDF file) – Company Profile “Milagen, Inc.: Revolutionizing predictive medicine and therapeutics” R.P.C. Valle, American Genomic/Proteomic Technology, pp 20-21
  • June 2002 – Intellectual Property/Technology Transfer Summit, Strategic Research Institute, July 18-19, 2002, Philadelphia, Panel on Proteomics, Invited Speaker, Dr. Rosaura Valle
  • May 14, 2002 – “The matching game” Randall C. Willis, Modern Drug Discovery, May 2002, Vol. 5, No. 5, pp 26-28, 30, 32-33, a review of Milagen and various protein-based chip companies, and their application in proteomics and diagnostics
  • May 14, 2002 – “A binding proposition,” Randall C. Willis, Modern Drug Discovery, May 2002, Vol. 5, No. 5, pp 47-49, more on Milagen and antibody array companies
  • May 14, 2002 (PDF file) – “Linking proteins to disease” R.P.C.Valle, C. Chavany, R. Hernandez-Gonzalez, M. Jendoubi, Current Drug Discovery, May 2002, pp 35-39, or how antibodies are used at Milagen to correlate gene products to disease phenotype
  • May 2002 – 4th Annual C21 Ventures – The future of BioVenture Investing, Techvision, May 6-8, 2002, San Diego, CA, Invited Speaker, Dr. Moncef Jendoubi
  • April 2002 – 93rd Annual Meeting, American Association for Cancer Research, April 6-10, 2002, San Francisco, CA, “AntibiomixTM: Antibody-based Target Discovery and Validation for Cancer by Matrix Protein Array” C. Chavany, J-F. Martini, R.P.C. Valle, M. Jendoubi, Poster Presentation, Dr. Christine Chavany
  • March 28, 2002 – Milagen’s AntibiomixTM Revolutionizes Antibody Chips for Predictive Medicine Using Biological Fluids , Press Release
  • March 18, 2002 – Emerging Microarray Technologies and Applications, IBC LifeSciences, March 18-19, 2002, San Diego, CA, “AntibiomixTM – High-throughput Target Validation and Large-scale Identification of Protein Functions” Invited Speaker, Dr. Moncef Jendoubi
  • March 2002 – Transcriptome 2002, The Institute for Genomic Research, March 10-13, 2002, Seattle, WA, “Breaking the bottle neck of Genomics and Proteomics,” Invited Speaker, Dr. Moncef Jendoubi
  • February 23, 2002 – CHI Genome Tri-Conference: Genomic Partnering, Human Genome Discovery, Gene Functional Analysis, February 23-24, 2002, Santa Clara, CA, “Immune System Stimulation to Rapidly Generate High-Avidity Polyclonal Antibodies”, Invited Speaker, Dr. Moncef Jendoubi
  • January/February 2002 (PDF file) – “Ascent of antibody,” Dr. Rathin Das, American Genomic/Proteomic Technology, March 2002, pp 6-7, Milagen is featured in the editor’s page focusing on the utility of antibodies as therapeutic agents and as drug discovery tools
  • January 28, 2002 – Drug Discovery Japan, CHI, January 28-31, 2002, Tokyo, Japan, “AntibiomixTM – A Paradigm Shift in High-throughput Target Validation”, Invited Speaker, Dr. Moncef Jendoubi